Today, the Centers for Medicare & Medicaid Services (CMS) issued a final rule for the Medicare Advantage (MA) and Part D prescription drug programs that will improve experiences for dually eligible beneficiaries and provide greater transparency for the MA and Part D programs.
Feb 10, 2022 Today the Centers for Medicare & Medicaid Services (CMS) is announcing a national coverage determination (NCD) that expands coverage for lung cancer screening with low dose computed tomography (LDCT) to improve health outcomes for people with lung cancer. Lung cancer is one of the most common cancers and the leading cause of cancer-related…
Today, the Centers for Medicare & Medicaid Services (CMS) released a proposed National Coverage Determination (NCD) decision memorandum. The proposed National Coverage Determination would cover Food and Drug Administration (FDA) approved monoclonal antibodies that target amyloid for the treatment of Alzheimer’s disease through coverage with evidence development (CED) – which means that FDA-approved drugs in this class would be covered for people with Medicare only if they are enrolled in qualifying clinical trials. The proposed National Coverage Determination is open to public comment for 30 days.
The Centers for Medicare & Medicaid Services (CMS) announced that Georgia will no longer have authority to require work activities as a condition of Medicaid eligibility, or charge premiums beyond those allowed under the Medicaid statute, in its Georgia Pathways to Coverage demonstration.
Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said Friday a new Alzheimer’s drug is responsible for about half of that.
Oct 22, 2021
Following the U.S. Food & Drug Administration’s (FDA) recent action that authorized a booster shot of the Moderna and Johnson & Johnson COVID-19 vaccines for certain populations and a recommendation from the Centers for Disease Control and Prevention (CDC), the Centers for Medicare & Medicaid Services (CMS) is reminding eligible consumers that coverage is available under Medicare, Medicaid, Children’s Health Insurance Program (CHIP), and in the commercial health insurance market for this critical protection from the virus, including booster shots from all three manufacturers, without cost sharing.
Medicare’s Open Enrollment period – also known as the Annual Election Period or Annual Coordinated Election Period – runs from October 15 through December 7. During this time all Medicare beneficiaries can reevaluate their coverage, and make changes, whether they are in Original/Traditional Medicare with separate Part D drug coverage, or in a private Medicare Advantage plan. Beneficiaries should review their coverage every year to determine if their current options meet their specific health care needs.
Written by Roz Plater on August 17, 2021 — Fact checked by Maria Gifford
The Centers for Medicare & Medicaid Services (CMS) in coordination with the Internal Revenue Service (IRS) is releasing guidance to ensure consumers continue to receive the tax credits they are eligible for through their Marketplace plan.
Jul 14, 2021 Today, the Centers for Medicare & Medicaid Services (CMS) released new enrollment reports showing more than two million people have signed up for health coverage during the Biden-Harris Administration’s 2021 Special Enrollment Period (SEP), which opened on February 15, 2021 as the country grappled with the pandemic, and will conclude on the…